Siddhartha Jaiswal
Affiliations: | Stanford University, Palo Alto, CA |
Area:
Aging, Stem cells, Cancer, MacrophagesGoogle:
"Siddhartha Jaiswal"Parents
Sign in to add mentor| Irving L. Weissman | grad student | 1999-2010 | |
| Benjamin Ebert | post-doc | 2013-2017 | (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schuermans A, Vlasschaert C, Nauffal V, et al. (2023) Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias. European Heart Journal |
| Yu Z, Filder TP, Ruan Y, et al. (2023) Genetic modification of inflammation and clonal hematopoiesis-associated cardiovascular risk. The Journal of Clinical Investigation |
| Weeks LD, Niroula A, Neuberg D, et al. (2023) Prediction of risk for myeloid malignancy in clonal hematopoiesis. Nejm Evidence. 2 |
| Wong WJ, Emdin C, Bick AG, et al. (2023) Author Correction: Clonal haematopoiesis and risk of chronic liver disease. Nature |
| Schuermans A, Nakao T, Ruan Y, et al. (2023) Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood. Journal of the American Heart Association. e030220 |
| Gumuser ED, Schuermans A, Cho SMJ, et al. (2023) Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology. 81: 1996-2009 |
| Wong WJ, Emdin C, Bick AG, et al. (2023) Clonal haematopoiesis and risk of chronic liver disease. Nature |
| Vlasschaert C, Mack T, Heimlich JB, et al. (2023) A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets. Blood |
| Ahmad H, Jahn N, Jaiswal S. (2022) Clonal Hematopoiesis and Its Impact on Human Health. Annual Review of Medicine. 74: 249-260 |
| Duncavage EJ, Bagg A, Hasserjian RP, et al. (2022) Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia. Blood |